Related Experiment Video
Updated: Jun 26, 2026

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
Cardiomyocyte remodeling in ischemic heart disease
Dalia Pangonyte1, Elena Stalioraityte, Reda Ziuraitiene
1Institute of Cardiology, Kaunas University of Medicine, Sukileliu 17, Kaunas, Lithuania. dalia.pangonyte@med.kmu.lt
Insights
Cardiomyocyte hypertrophy, an enlargement of heart muscle cells, occurs before the first myocardial infarction in ischemic heart disease (IHD). This cellular change precedes significant heart tissue loss, indicating early cardiac remodeling.
Area of Science:
- Cardiovascular Pathology
- Cardiac Histomorphometry
- Ischemic Heart Disease Research
Background:
- Ischemic heart disease (IHD) involves chronic ischemia and cardiac tissue loss.
- Left ventricular cardiomyocyte size and shape changes are key indicators of cardiac response.
- Understanding these changes is crucial for diagnosing and managing IHD progression.
Purpose of the Study:
- To detect alterations in left ventricular cardiomyocyte size and shape.
- To investigate these changes in response to chronic ischemia and myocardial infarction.
- To determine the timing of these cellular changes within the course of IHD.
Main Methods:
- Histomorphometric analysis of left ventricular cardiomyocyte dimensions (diameter, length).
- Assessment of cardiomyocyte cross-sectional area and volume.
- Comparison between preinfarction IHD, postinfarction IHD, and control groups.
Main Results:
- Significant cardiomyocyte hypertrophy (32.0% volume increase) was observed in the preinfarction IHD group compared to controls.
- Preinfarction IHD group showed increased cross-sectional area (17.2%) and length (12.5%).
- No significant differences in cardiomyocyte parameters were found between preinfarction and postinfarction IHD groups.
Conclusions:
- Left ventricular cardiomyocyte hypertrophy precedes the first myocardial infarction in IHD.
- Cardiomyocyte dimensions remain stable post-myocardial infarction until congestive heart failure develops.
- Early cellular hypertrophy is a hallmark of preinfarction IHD.
Objective:
The aim of the study was to detect changes in left ventricular cardiomyocyte size and shape in response to chronic ischemia and loss of cardiac tissue (myocardial infarction) during the course of ischemic heart disease (IHD).
Material And Methods:
Left ventricular cardiomyocyte dimensions (diameter and length) were estimated histomorphometrically, and their cross-sectional area and volume were assessed in 85 males who died suddenly out of hospital (within 6 hours of the onset of the terminal event) due to the acute first (preinfarction IHD group, n=53, aged 48.6+/-2.9 years) or repeated (postinfarction IHD group, n=32, aged 51.7+/-2.9 years) IHD attack, and had no other causes for the increased heart load. Twenty-nine males of similar age (mean age, 46.0+/-3.1 years) who succumbed to external causes served as controls.
Results:
We have found cardiomyocyte hypertrophy in the preinfarction IHD group already. The cardiomyocyte volume was increased by 32.0% in comparison with the same index in the control group, and cross-sectional area and length--by 17.2 and 12.5%, respectively. In postinfarction IHD group, all studied cardiomyocyte parameters did not differ significantly from the analogous indices in the preinfarction IHD group (P>0.05). Cardiomyocyte hypertrophy was related to the increase in left ventricular cardiomyocyte parameters.
Conclusions:
Left ventricular cardiomyocyte hypertrophy occurs before the first myocardial infarction. In postinfarction myocardium, cardiomyocyte dimensions do not differ significantly at least prior to the appearance of congestive heart failure syndrome.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy
Pathophysiology of Heart Failure
